Reviewing "The Myth of The Paperless Office" for the New Yorker in 2002, Malcolm Gladwell argued that if the computer had come first, and paper didn't exist, someone would have had to invent it.  Paper, it turns out, is a lot more useful than we typically appreciate.

Biopharma – especially big pharma – gets all sorts of grief for being large, stodgy, and unable to innovate (or evolve); this Corey Goodman interview represents the perspective well.

Before writing off these companies entirely, however (an ignorant reaction in any case),...

Perhaps it's the sweet California air, but the pervasive (though not universal) pessimism in biopharma these days is really bumming me out.  Consequently, I'd like to discuss three potential responses to difficult industry problems.

Cosponsored by AEI and the Engelberg Center for Health Care Reform at Brookings Institution, this conference on regulating medical devices will convene stakeholders to discuss current challenges and feasible solutions that protect public health while encouraging the development, approval, and reimbursement of effective technologies.

Scott Gottlieb reviews Eric Topol's book on how medical innovation will coalesce to change clinical practice and what the coming changes mean for today's policy debates.

A few quick impressions from last night’s FutureMed extravaganza put on by Singularity University at the Museum of Computer History, a stone’s throw from Google’s Mountain View headquarters.

The event featured an exhibition session where emerging digital health...

New medical technologies are often argued to be a leading force behind the growth in health care spending.

Scott Gottlieb's testimony on the Independent Payment Advisory Board for the Committee on Ways and Means' subcommittee on health.